- Home
- ONCY vs AIRG Comparison
ONCY vs AIRG Comparison
Compare ONCY & AIRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- AIRG
- Stock Information
- Founded
- ONCY 1998
- AIRG 1995
- Country
- ONCY Canada
- AIRG United States
- Employees
- ONCY N/A
- AIRG N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- AIRG Radio And Television Broadcasting And Communications Equipment
- Sector
- ONCY Health Care
- AIRG Technology
- Exchange
- ONCY Nasdaq
- AIRG Nasdaq
- Market Cap
- ONCY 49.1M
- AIRG 48.7M
- IPO Year
- ONCY 1999
- AIRG 2016
- Fundamental
- Price
- ONCY $0.34
- AIRG $4.03
- Analyst Decision
- ONCY Strong Buy
- AIRG Strong Buy
- Analyst Count
- ONCY 4
- AIRG 2
- Target Price
- ONCY $4.33
- AIRG $9.25
- AVG Volume (30 Days)
- ONCY 820.6K
- AIRG 11.7K
- Earning Date
- ONCY 05-14-2025
- AIRG 05-07-2025
- Dividend Yield
- ONCY N/A
- AIRG N/A
- EPS Growth
- ONCY N/A
- AIRG N/A
- EPS
- ONCY N/A
- AIRG N/A
- Revenue
- ONCY N/A
- AIRG $58,381,000.00
- Revenue This Year
- ONCY N/A
- AIRG N/A
- Revenue Next Year
- ONCY N/A
- AIRG $23.54
- P/E Ratio
- ONCY N/A
- AIRG N/A
- Revenue Growth
- ONCY N/A
- AIRG 8.46
- 52 Week Low
- ONCY $0.34
- AIRG $3.17
- 52 Week High
- ONCY $1.53
- AIRG $10.34
- Technical
- Relative Strength Index (RSI)
- ONCY 24.92
- AIRG 49.56
- Support Level
- ONCY $0.34
- AIRG $3.85
- Resistance Level
- ONCY $0.45
- AIRG $4.35
- Average True Range (ATR)
- ONCY 0.04
- AIRG 0.20
- MACD
- ONCY -0.01
- AIRG -0.00
- Stochastic Oscillator
- ONCY 2.50
- AIRG 36.33
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.